The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 1b study with PEGylated human IL-10 (AM0010) with 5-FU and oxaliplatin (FOLFOX) in metastatic pancreatic adenocarcinoma (PDAC).
 
J. Randolph Hecht
Consulting or Advisory Role - Amgen; ARMO BioSciences; Boston Biologics; Cornerstone Pharmaceuticals; Forty Seven; Insys Therapeutics; Novocure
Research Funding - Amgen (Inst); ARMO BioSciences (Inst); Halozyme (Inst); Merrimack (Inst)
 
Aung Naing
Research Funding - Amplimmune; ARMO BioSciences; Atterocor; Baxter (I); EMD Serono; Healios; Incyte; Karyopharm Therapeutics; MedImmune; NCI; Novartis; Regeneron
Travel, Accommodations, Expenses - ARMO BioSciences
 
Gerald Falchook
No Relationships to Disclose
 
Manish R. Patel
No Relationships to Disclose
 
Jeffrey R. Infante
No Relationships to Disclose
 
Raid Aljumaily
No Relationships to Disclose
 
Deborah Jean Lee Wong
Honoraria - Bristol-Myers Squibb
Consulting or Advisory Role - Bristol-Myers Squibb
Research Funding - ARMO BioSciences; AstraZeneca/MedImmune; BioMed Valley Discoveries; Kura Oncology; Merck Serono; Merck Sharp & Dohme
 
Karen A. Autio
No Relationships to Disclose
 
Zev A. Wainberg
Consulting or Advisory Role - Amgen; Sirtex Medical; Taiho Pharmaceutical
Speakers' Bureau - Genentech
Research Funding - Biomarin (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Plexxikon (Inst)
Travel, Accommodations, Expenses - Amgen; Genentech; Lilly
 
Milind M. Javle
No Relationships to Disclose
 
Johanna C. Bendell
Research Funding - Apexigen (Inst); Array BioPharma (Inst); AstraZeneca/MedImmune (Inst); Bayer (Inst); Boston Biomedical (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Daiichi Sankyo (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); GlaxoSmithKline (Inst); Incyte (Inst); Kolltan Pharmaceuticals (Inst); Leap Therapeutics (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); Oncogenex (Inst); OncoMed (Inst); SynDevRx (Inst); Taiho Pharmaceutical (Inst)
 
Shubham Pant
Consulting or Advisory Role - Celgene; Halozyme
 
Peter Van Vlasselaer
Employment - ARMO BioSciences
Leadership - ARMO BioSciences
 
Gail Linda Brown
Employment - ARMO BioSciences
 
Martin Oft
Employment - ARMO BioSciences
 
Kyriakos P. Papadopoulos
Research Funding - Abbvie (Inst); ARMO BioSciences (Inst); ArQule (Inst); Daiichi Sankyo (Inst); GlaxoSmithKline (Inst); MedImmune (Inst); Novartis (Inst); Onyx (Inst); Regeneron (Inst); Sanofi (Inst)